These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 35882293)
1. Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy. Luo L; Luo J; Cai Y; Fu M; Li W; Shi L; Liu J; Dong R; Xu X; Tu L; Yang Y Pharmacol Res; 2022 Sep; 183():106367. PubMed ID: 35882293 [TBL] [Abstract][Full Text] [Related]
2. Effects of the prebiotic inulin-type fructans on post-antibiotic reconstitution of the gut microbiome. Tao C; Zeng W; Zhang Q; Liu G; Wu F; Shen H; Zhang W; Bo H; Shao H J Appl Microbiol; 2021 Mar; 130(3):634-649. PubMed ID: 32813896 [TBL] [Abstract][Full Text] [Related]
3. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A. Li YJ; Chen X; Kwan TK; Loh YW; Singer J; Liu Y; Ma J; Tan J; Macia L; Mackay CR; Chadban SJ; Wu H J Am Soc Nephrol; 2020 Jun; 31(6):1267-1281. PubMed ID: 32358041 [TBL] [Abstract][Full Text] [Related]
4. Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels. Valcheva R; Koleva P; Martínez I; Walter J; Gänzle MG; Dieleman LA Gut Microbes; 2019; 10(3):334-357. PubMed ID: 30395776 [TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice. Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673 [TBL] [Abstract][Full Text] [Related]
6. Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction. Catry E; Bindels LB; Tailleux A; Lestavel S; Neyrinck AM; Goossens JF; Lobysheva I; Plovier H; Essaghir A; Demoulin JB; Bouzin C; Pachikian BD; Cani PD; Staels B; Dessy C; Delzenne NM Gut; 2018 Feb; 67(2):271-283. PubMed ID: 28377388 [TBL] [Abstract][Full Text] [Related]
7. Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota. Deng L; Yang Y; Xu G Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Dec; 1867(12):159234. PubMed ID: 36185030 [TBL] [Abstract][Full Text] [Related]
8. Specific inulin-type fructan fibers protect against autoimmune diabetes by modulating gut immunity, barrier function, and microbiota homeostasis. Chen K; Chen H; Faas MM; de Haan BJ; Li J; Xiao P; Zhang H; Diana J; de Vos P; Sun J Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28218451 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol improves diabetic kidney disease by modulating the gut microbiota-short chain fatty acids axis in Yan H; Zhang Y; Lin X; Huang J; Zhang F; Chen C; Ren H; Zheng S; Yang J; Hui S Int J Food Sci Nutr; 2024 May; 75(3):264-276. PubMed ID: 38238900 [TBL] [Abstract][Full Text] [Related]
10. The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment. Li Y; Su X; Gao Y; Lv C; Gao Z; Liu Y; Wang Y; Li S; Wang Z Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165764. PubMed ID: 32169506 [TBL] [Abstract][Full Text] [Related]
11. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury. Cai K; Ma Y; Cai F; Huang X; Xiao L; Zhong C; Ren P; Luo Q; Chen J; Han F Endocrine; 2022 May; 76(2):294-303. PubMed ID: 35246764 [TBL] [Abstract][Full Text] [Related]
12. Effect of chicory inulin-type fructan-containing snack bars on the human gut microbiota in low dietary fiber consumers in a randomized crossover trial. Reimer RA; Soto-Vaca A; Nicolucci AC; Mayengbam S; Park H; Madsen KL; Menon R; Vaughan EE Am J Clin Nutr; 2020 Jun; 111(6):1286-1296. PubMed ID: 32320024 [TBL] [Abstract][Full Text] [Related]
13. Friend or foe? The roles of inulin-type fructans. Man S; Liu T; Yao Y; Lu Y; Ma L; Lu F Carbohydr Polym; 2021 Jan; 252():117155. PubMed ID: 33183606 [TBL] [Abstract][Full Text] [Related]
14. The impact of long-term dietary pattern of fecal donor on in vitro fecal fermentation properties of inulin. Yang J; Rose DJ Food Funct; 2016 Apr; 7(4):1805-13. PubMed ID: 26583778 [TBL] [Abstract][Full Text] [Related]
15. A graminan type fructan from Achyranthes bidentata prevents the kidney injury in diabetic mice by regulating gut microbiota. Si H; Chen Y; Hu D; Yao S; Yang J; Wen X Carbohydr Polym; 2024 Sep; 339():122275. PubMed ID: 38823933 [TBL] [Abstract][Full Text] [Related]
16. Liu W; Xu S; Zhang B; Sun X Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064789 [TBL] [Abstract][Full Text] [Related]
17. Effects of prebiotic inulin-type fructans on blood metabolite and hormone concentrations and faecal microbiota and metabolites in overweight dogs. Alexander C; Cross TL; Devendran S; Neumer F; Theis S; Ridlon JM; Suchodolski JS; de Godoy MRC; Swanson KS Br J Nutr; 2018 Sep; 120(6):711-720. PubMed ID: 30064535 [TBL] [Abstract][Full Text] [Related]
18. Inulin Supplementation Alleviates Ochratoxin A-Induced Kidney Injury through Modulating Intestinal Microbiota. Wang J; Jiang M; Li X; Ye Y; Xie Y; Wu T; Chen Y; Yu H; Wu H; Yang Z; Zhou E J Agric Food Chem; 2024 Aug; 72(33):18682-18696. PubMed ID: 39135376 [TBL] [Abstract][Full Text] [Related]
19. Inulin Fermentable Fiber Ameliorates Type I Diabetes via IL22 and Short-Chain Fatty Acids in Experimental Models. Zou J; Reddivari L; Shi Z; Li S; Wang Y; Bretin A; Ngo VL; Flythe M; Pellizzon M; Chassaing B; Gewirtz AT Cell Mol Gastroenterol Hepatol; 2021; 12(3):983-1000. PubMed ID: 33940221 [TBL] [Abstract][Full Text] [Related]
20. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease. Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]